Key facts
- This page summarizes Deborah H. Telman's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 13 Nov 2025, 19:36.
Deborah H. Telman - 12 Nov 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)
- Reporting relationship
- EVP, Corporate Affairs & GC
- Issuer ticker
- GILD
- Reported as of
- 12 Nov 2025
- Net transaction value
- -$3,084,602
- SEC form
- 4
- Accepted by SEC
- 13 Nov 2025, 19:36:11 UTC
- Prior SEC filing
- 27 Oct 2025
- Next SEC filing
- 20 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Deborah H. Telman filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 13 Nov 2025.
Change
- Previous filing in this sequence was filed on 27 Oct 2025.
- Current net transaction value: -$3,084,602.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001860008
Primary reporting owner
Telman Deborah H
- Relationship
- EVP, Corporate Affairs & GC
- Address
- GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY
- Signature
- /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
- Signature date
- 13 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- $1,290,637
- Shares
- +17,181
- Change %
- +39%
- Price
- $75.12
- Shares after
- 60,857
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Sale
- Transaction value
- $2,130,444
- Shares
- -17,181
- Change %
- -28%
- Price
- $124.00
- Shares after
- 43,676
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- $2,184,874
- Shares
- +35,965
- Change %
- +82%
- Price
- $60.75
- Shares after
- 79,641
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Sale
- Transaction value
- $4,398,591
- Shares
- -35,965
- Change %
- -45%
- Price
- $122.30
- Shares after
- 43,676
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F2
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- $30,375
- Shares
- +500
- Change %
- +1.1%
- Price
- $60.75
- Shares after
- 44,176
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
GILD
transaction
Common Stock
Sale
- Transaction value
- $61,452
- Shares
- -500
- Change %
- -1.1%
- Price
- $122.90
- Shares after
- 43,676
- Date
- 12 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -17,181
- Change %
- -31%
- Price
- $0.000000
- Shares after
- 37,799
- Date
- 12 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,181
- Exercise price
- $75.12
- Footnotes
- F1, F4
GILD
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -35,965
- Change %
- -74%
- Price
- $0.000000
- Shares after
- 12,655
- Date
- 12 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,965
- Exercise price
- $60.75
- Footnotes
- F1, F4
GILD
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -500
- Change %
- -4%
- Price
- $0.000000
- Shares after
- 12,155
- Date
- 12 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $60.75
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
The transactions reported in the Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
Footnote F2
Sales prices for the transactions reported here range from $121.87 to $122.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Footnote F3
Sales prices for the transactions reported here range from $122.88 to $122.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Footnote F4
The stock options have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.